Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

HealthLynked (HLYK) FCF Margin (2016 - 2025)

HealthLynked (HLYK) has disclosed FCF Margin for 10 consecutive years, with 114.35% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin rose 6137.0% to 114.35% in Q3 2025 year-over-year; TTM through Sep 2025 was 85.84%, a 3297.0% increase, with the full-year FY2024 number at 116.23%, down 4377.0% from a year prior.
  • FCF Margin was 114.35% for Q3 2025 at HealthLynked, down from 70.49% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 121.04% in Q4 2021 to a low of 175.72% in Q3 2024.
  • A 5-year average of 66.18% and a median of 80.85% in 2021 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: skyrocketed 62505bps in 2021, then tumbled -20867bps in 2023.
  • HealthLynked's FCF Margin stood at 121.04% in 2021, then tumbled by -33bps to 80.63% in 2022, then crashed by -259bps to 128.04% in 2023, then rose by 6bps to 120.14% in 2024, then increased by 5bps to 114.35% in 2025.
  • Per Business Quant, the three most recent readings for HLYK's FCF Margin are 114.35% (Q3 2025), 70.49% (Q2 2025), and 55.87% (Q1 2025).